Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

All Publications

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.

Journal article

Kaplonek P. et al, (2023), Nature immunology

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface

Preprint

Zhang P. et al, (2023)

CD4+ T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4+ Cells.

Journal article

Brenna E. et al, (2020), Cell reports, 30, 137 - 152.e5

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

Journal article

López-Camacho C. et al, (2018), Nature Communications, 9

Transcriptomic profiling facilitates classification of response to influenza challenge

Journal article

Davenport EE. et al, (2015), Journal of Molecular Medicine, 93, 105 - 114

Transcriptomic profiling facilitates classification of response to influenza challenge

Journal article

Davenport EE. et al, (2015), Journal of Molecular Medicine, 93, 105 - 114

Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine

Journal article

Powell TJ. et al, (2013), PLoS ONE, 8, e62778 - e62778

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

Journal article

Lillie PJ. et al, (2012), Clinical Infectious Diseases, 55, 19 - 25

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence

Journal article

Smith CL. et al, (2005), Int J Cancer, 113, 259 - 266

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Journal article

Palmowski MJ. et al, (2002), J Immunol, 168, 4391 - 4398

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.

Journal article

Hanke T. et al, (1998), Journal of General Virology, 79, 83 - 90